Samuel Frank

Summary

Affiliation: Boston University
Country: USA

Publications

  1. ncbi Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease
    Samuel Frank
    Boston University School of Medicine, 72 East Concord St, C329, Boston, Massachusetts, USA
    Neuropsychiatr Dis Treat 6:657-65. 2010
  2. ncbi Trauma-induced spinal vascular event producing hemipseudoathetosis
    Samuel Frank
    Department of Neurology, Boston University, Boston, Massachusetts 02118, USA
    Mov Disord 20:1378-80. 2005
  3. ncbi What is the risk of sham surgery in Parkinson disease clinical trials? A review of published reports
    Samuel Frank
    Boston University, MA, USA
    Neurology 65:1101-3. 2005
  4. ncbi Teaching residents to be teachers
    Samuel Frank
    Boston University School of Medicine, Boston, MA 02118, USA
    Nat Clin Pract Neurol 3:236-7. 2007
  5. ncbi Ethics of sham surgery: perspective of patients
    Samuel A Frank
    Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA
    Mov Disord 23:63-8. 2008
  6. ncbi A study of chorea after tetrabenazine withdrawal in patients with Huntington disease
    Samuel Frank
    Department of Neurology, Boston University School of Medicine, Boston, MA, USA
    Clin Neuropharmacol 31:127-33. 2008
  7. ncbi Advances in the pharmacological management of Huntington's disease
    Samuel Frank
    Boston University School of Medicine, Boston, Massachusetts, USA
    Drugs 70:561-71. 2010
  8. ncbi The neurology resident as teacher: evaluating and improving our role
    David J Gill
    Department of Neurology, University of Rochester, Box 673, 601 Elmwood Ave, Rochester, NY 14642, USA
    Neurology 63:1334-8. 2004
  9. ncbi The challenges of residents teaching neurology
    Samuel A Frank
    University of Rochester, NY 14620, USA
    Neurologist 10:216-20. 2004

Detail Information

Publications9

  1. ncbi Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease
    Samuel Frank
    Boston University School of Medicine, 72 East Concord St, C329, Boston, Massachusetts, USA
    Neuropsychiatr Dis Treat 6:657-65. 2010
    ..There are no current treatments to change the course of HD, but education and symptomatic therapies can be effective tools for clinicians to use with patients and families affected by HD...
  2. ncbi Trauma-induced spinal vascular event producing hemipseudoathetosis
    Samuel Frank
    Department of Neurology, Boston University, Boston, Massachusetts 02118, USA
    Mov Disord 20:1378-80. 2005
    ..We report on a patient with spinal pseudoathetosis secondary to posterior column vascular incident and physical injury. This unusual case highlights sensory system abnormalities as a cause of movement disorders...
  3. ncbi What is the risk of sham surgery in Parkinson disease clinical trials? A review of published reports
    Samuel Frank
    Boston University, MA, USA
    Neurology 65:1101-3. 2005
    ..Placebo surgeries were generally safe and well tolerated but the number of subjects receiving the procedure was small. Harm occurred more frequently in subjects randomized to the experimental intervention...
  4. ncbi Teaching residents to be teachers
    Samuel Frank
    Boston University School of Medicine, Boston, MA 02118, USA
    Nat Clin Pract Neurol 3:236-7. 2007
  5. ncbi Ethics of sham surgery: perspective of patients
    Samuel A Frank
    Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA
    Mov Disord 23:63-8. 2008
    ..Future research needs to determine whether eliciting more considered judgments of laypersons would reveal different levels of support for sham surgery...
  6. ncbi A study of chorea after tetrabenazine withdrawal in patients with Huntington disease
    Samuel Frank
    Department of Neurology, Boston University School of Medicine, Boston, MA, USA
    Clin Neuropharmacol 31:127-33. 2008
    ..To assess tetrabenazine (TBZ) efficacy by evaluating the change in Huntington disease-associated chorea resulting from TBZ treatment withdrawal...
  7. ncbi Advances in the pharmacological management of Huntington's disease
    Samuel Frank
    Boston University School of Medicine, Boston, Massachusetts, USA
    Drugs 70:561-71. 2010
    ..Although there is no current method to change the course of this devastating disease, education and symptomatic therapies are effective tools available to clinicians and the families affected by HD...
  8. ncbi The neurology resident as teacher: evaluating and improving our role
    David J Gill
    Department of Neurology, University of Rochester, Box 673, 601 Elmwood Ave, Rochester, NY 14642, USA
    Neurology 63:1334-8. 2004
    ..There continues to be a need for studies specifically addressing the teaching by neurology residents and fellows...
  9. ncbi The challenges of residents teaching neurology
    Samuel A Frank
    University of Rochester, NY 14620, USA
    Neurologist 10:216-20. 2004
    ..Teaching also reinforces knowledge, and residents will likely be better practitioners if some basic skills of teaching are practiced...